Skip to main content
OpenTrials
Completed

NCT Number: NCT04758520

Usability and Acceptance of a New Robotic Exoskeleton for Shoulder Rehabilitation

The purpose of this pilot study is to validate the safety, reliability and usability of FLOAT medical device, a prototypal robotic system for the rehabilitation of the shoulder, designed and developed in the Rehab Technologies IIT-INAIL Lab to fulfil the needs orthopaedic conditions. The acceptance from patients and therapists will be assessed after a single session of robotic therapy in a sample of injured workers suffering from post-traumatic or post-surgical shoulder disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

INAIL - Centro di Riabilitazione Motoria di Volterra

Volterra, Pisa, 56048, Italy

About this study

This study aims to:

  • Test the safety and reliability of the FLOAT device for delivering post-acute motor and functional rehabilitation of patients with orthopaedic shoulder dysfunction.
  • Assess the three different modalities of utilization of the exoskeleton (Passive Mode, Learn&Repeat Mode, Transparency Mode).
  • Evaluate the usability of the device in terms of comfort, adaptability to different patients' anthropometrics, general functioning and overall satisfaction.

Six injured workers with shoulder post-traumatic and post-operative dysfunction will be enrolled in a single testing session at the INAIL Rehabilitation Center in Volterra. Pilot testing of FLOAT device will focus mainly on the feasibility of implementing the multiple operating modes of the new device, recording patients and therapist's feedback. The session will last about 3 hours and all exercises will be administered by a trained physical therapist supported by a member of the engineering team.

For Aim 1, Safety and Reliability of the device will be evaluated in terms of the number of adverse events and malfunctions occurring during the study session.

For Aim 2, each modality will be assessed by means of the Numeric Pain Rating Scale (NPRS), The Borg CR10 Scale Perceived Exertion (only for the Transparent mode) and ad-hoc clinician-generated questionnaires for both patients and therapists.

For aim 3, patient and therapist's general evaluation about usability will be detected through a final ad-hoc questionnaire.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Height between 160 and 185 cm;
  • Distance between the shoulder joint center and the sagittal plane between 156 and 197 mm;
  • Shoulder joint center to wall distance between 82 and 142 mm
  • Maximum shoulter radius: 120 mm
  • Distance between the shoulder joint center and the elbow joint center between 250 and 303 mm
  • Time from acute event ≥ 60 days
  • Right shoulder joint disfunction after orthopaedic injury or surgery as a result of work accidents
  • Post-immobilization phase
  • At least 80° shoulder passive flexion and 45° shoulder passive abduction
  • Pain intensity on movement < 6 NRS;

Exclusion criteria

  • Glenohumeral joint instability
  • Shoulder Prosthetic implants
  • Upper arm sensorimotor deficits
  • Chronic inflammatory disorder involving upper arm joints
  • Pseudoarthrosis of the proximal humerus fractures
  • Spinal fractures within the last 3 months
  • Open skin at the level of the patient-device interface
  • Current or prior history of malignancy
  • Pregnancy or breast feeding

Treatment and study plan

FLOAT upper limb exoskeleton

Device

The FLOAT device is composed by a wearable exoskeleton assembled on a poly-articulated arm that, in turn, is mounted on a support base with unlockable wheels. The exoskeleton includes 5 motors arranged in a way that, when generating movement, ensures the optimal involvement of all the articulations of the shoulder complex, particularly the glenohumeral and the scapulothoracic joints. According to the chosen modality of use of the exoskeleton, the device allows patient's passive or active-assisted mobilization. The poly-articulated arm supporting the exoskeleton is capable to compensate exoskeleton weight in every configuration and, if configured appropriately, permits exoskeleton use both in seated and standing positions. The support base of the device has unlockable wheels that, if unlocked, permit the free movement of the patient in the workspace, enabling the performance of more complex functional activities while assisted by the exoskeleton.

Primary outcomes

  1. Number of adverse events

    Time frame: 1 year

    The physiotherapist is required to report any adverse events occurring during the study in regard to the use of FLOAT, for the purpose of evaluating the safety of the device

  2. Number of device malfunctions

    Time frame: 1 year

    The physiotherapist is required to report any malfunctions occurring during the study in regard to the use of FLOAT, for the purpose of evaluating the reliability of the device

Secondary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    Time frame: 1 year

    NPRS is an 11-point scale for patient self-reporting of pain, with 0 being "no pain" and 10 being "the worst pain imaginable"; It will be administered after each series of joint mobilization exercises.

  2. The Borg Category-Ratio Scale (CR-10)

    Time frame: 1 year

    The Borg CR10 Scale is a tool for estimating effort and exertion, breathlessness, and fatigue during physical work, with rating ranges from 0 (nothing at all) to 10 (extremely strong).

    It will be administered after each series of functional tasks in transparent mode

  3. Ad-hoc questionnaires for the patient, one for each of the three modalities (for a total amount of 3 questionnaires)

    Time frame: After the completion of the testing session with each of the three modalities

    Clinician-generated questionnaire to investigate patients' impressions about the physical interaction with the robotic device using the specific modality. Each questionnaire consists of a series of items with 5-point rating scale (1= not at all, 5=very well)

  4. Ad-hoc questionnaires for the therapist, one for each of the three modalities (for a total amount of 3 questionnaires)

    Time frame: 1 year

    Clinician-generated questionnaire to investigate therapist's impressions about the usability and efficiency the robotic device using the specific modality. It will be administered after the completion of the testing session with each of the three modalities. Each questionnaire consists of a series of items with 5-point rating scale (1=not at all, 5=very well)

  5. Ad-hoc questionnaire for the patient (final evaluation)

    Time frame: 1 year (at the end of the study)

    Clinician-generated questionnaire to investigate patients' general evaluation about FLOAT usability. The questionnaire consists of a series of items with 5-point rating scale (1=not at all, 5=very well)

  6. Ad-hoc questionnaire for the therapist (final evaluation)

    Time frame: 1 year (at the end of the study)

    Clinician-generated questionnaire to investigate therapists' general evaluation about FLOAT usability. The questionnaire consists of a series of items with 5-point rating scale (1=not at all, 5=very well)

Sponsors and collaborators

Lead sponsor

Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro

Other

Collaborators

  • Istituto Italiano di Tecnologia

Registry information

Official study title

Motor Rehabilitation of the Shoulder Complex After Orthopaedic Injury or Surgery Because of Work Accidents: a Pilot Study.

Acronym: CRMINAIL08

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Feb 17, 2021
Registry last updated
Mar 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.